ASRT
Assertio Therapeutics IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$139.50M
P/E Ratio
—
EPS
$-5.55
Beta
0.45
52W High
$21.71
52W Low
$8.61
50-Day MA
$15.83
200-Day MA
$12.73
Dividend Yield
—
Profit Margin
-25.60%
Forward P/E
625.00
PEG Ratio
0.90
About Assertio Therapeutics Inc
Assertio Holdings, Inc., a commercial pharmaceutical company, provides medications in the areas of neurology, hospital, and pain and inflammation. The company is headquartered in Lake Forest, Illinois.
Fundamentals
| Revenue (TTM) | $118.71M |
| Gross Profit (TTM) | $83.33M |
| EBITDA | $12.78M |
| Operating Margin | -105.20% |
| Return on Equity | -28.20% |
| Return on Assets | -3.90% |
| Revenue/Share (TTM) | $18.54 |
| Book Value | $14.63 |
| Price-to-Book | 1.27 |
| Price-to-Sales (TTM) | 1.18 |
| EV/Revenue | 0.807 |
| EV/EBITDA | 35.96 |
| Quarterly Earnings Growth (YoY) | -18.80% |
| Quarterly Revenue Growth (YoY) | -57.90% |
| Shares Outstanding | $6.46M |
| Float | $5.63M |
| % Insiders | 1.70% |
| % Institutions | 34.27% |
Historical Volatility
HV 10-Day
78.62%
HV 20-Day
59.07%
HV 30-Day
79.75%
HV 60-Day
67.04%
HV Rank
100.0%
Volatility is currently contracting
Analyst Ratings
Consensus ($21.33 target)
1
Strong Buy3
BuyMore HEALTHCARE Stocks
Data last updated: 5/5/2026